Orthofix International N.V. (NASDAQ:OFIX) released its quarterly earnings data on Monday. The medical device company reported $0.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.01, Bloomberg Earnings reports. Orthofix International N.V. had a positive return on equity of 10.03% and a negative net margin of 0.82%. The business had revenue of $108.90 million for the quarter, compared to analyst estimates of $102.94 million. During the same quarter in the prior year, the firm posted $0.41 EPS. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Orthofix International N.V. updated its FY17 guidance to $1.54-1.60 EPS.

Shares of Orthofix International N.V. (OFIX) traded up 1.98% on Monday, hitting $44.85. The stock had a trading volume of 110,598 shares. The firm has a 50 day moving average of $45.55 and a 200 day moving average of $40.42. Orthofix International N.V. has a 12 month low of $32.51 and a 12 month high of $47.18. The stock’s market cap is $809.27 million.

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. State Street Corp raised its position in shares of Orthofix International N.V. by 5.6% in the fourth quarter. State Street Corp now owns 364,267 shares of the medical device company’s stock worth $13,179,000 after buying an additional 19,395 shares in the last quarter. Norges Bank acquired a new position in shares of Orthofix International N.V. during the fourth quarter worth $5,664,000. Teachers Advisors LLC raised its position in shares of Orthofix International N.V. by 18.2% in the fourth quarter. Teachers Advisors LLC now owns 35,600 shares of the medical device company’s stock worth $1,288,000 after buying an additional 5,489 shares in the last quarter. Capstone Asset Management Co. acquired a new position in shares of Orthofix International N.V. during the first quarter worth $204,000. Finally, Louisiana State Employees Retirement System acquired a new position in shares of Orthofix International N.V. during the first quarter worth $278,000. 99.68% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “Orthofix International N.V. (OFIX) Announces Quarterly Earnings Results” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.americanbankingnews.com/2017/08/07/orthofix-international-n-v-nasdaqofix-releases-quarterly-earnings-results-beats-expectations-by-0-05-eps.html.

Several equities research analysts have commented on OFIX shares. BidaskClub lowered Orthofix International N.V. from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. Zacks Investment Research upgraded Orthofix International N.V. from a “sell” rating to a “hold” rating in a research report on Thursday, July 6th. Ladenburg Thalmann Financial Services started coverage on Orthofix International N.V. in a research report on Wednesday, June 14th. They issued a “buy” rating and a $53.25 price objective on the stock. SunTrust Banks, Inc. started coverage on Orthofix International N.V. in a research report on Tuesday, May 23rd. They issued a “buy” rating and a $49.00 price objective on the stock. Finally, BTIG Research started coverage on Orthofix International N.V. in a research report on Wednesday, June 21st. They issued a “buy” rating and a $52.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $51.88.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Earnings History for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.